Fosamax Lawsuit Update: Next Status Conference in New Jersey State Fosamax Litigation Scheduled for December 18th, Bernstein Liebhard LLP Reports

Share Article

Bernstein Liebhard LLP is actively evaluating Fosamax lawsuits on behalf of individuals who suffered atypical femur fractures allegedly due to their use of Fosamax.

Bernstein Liebhard LLP | Consumer Injury Lawyers
We are encouraged to see the Fosamax litigation moving forward. We continue to hear from individuals who suffered debilitating femur fractures potentially associated with long-term use of this drug,

The next status conference scheduled for hundreds of Fosamax lawsuits now pending in New Jersey Superior Court, Atlantic County, is scheduled for December 18, 2012 at 10:00 a.m. Lawsuits filed in the litigation allege Fosamax caused plaintiffs to suffer serious side effects, including atypical femur fractures (In re: Fosamax Litigation, No. 282, N.J. Super. Ct).*

“We are encouraged to see the Fosamax litigation moving forward. We continue to hear from individuals who suffered debilitating femur fractures potentially associated with long-term use of this drug,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The firm is actively filing Fosamax femur fracture lawsuits in the New Jersey Superior Court proceeding.

Fosamax Femur Fracture Lawsuits
Fosamax and other bisphosphonates are used to treat bone weakening diseases, including osteoporosis. These medications were the subject of a U.S. Food & Drug Administration (FDA) advisory issued in October 2010, after studies indicated that people taking bisphosphonates for osteoporosis are at risk of suffering atypical femur fractures.** An FDA-commissioned analysis published in the New England Journal of Medicine this past May found that there was little benefit in taking bisphosphonates for longer than five years due to their association with serious side effects, including atypical femur fractures.***

In addition to the consolidated Fosamax litigation now underway in New Jersey Superior Court, additional Fosamax femur fracture lawsuits are pending in a multidistrict litigation established in U.S. District Court, District of New Jersey (In re: Fosamax (Alendronate Sodium) Products Liability Litigation (No. II) - MDL No. 2243). According to court records, the first Fosamax femur fracture trials in both the state and federal litigations are expected to begin next Spring.

Fosamax users who suffered femur fractures possibly associated with this medication could be entitled to compensation for their medical bills, lost wages and pain and suffering. A wealth of information regarding Fosamax lawsuits is available by visiting Bernstein Liebhard LLP’s website, To arrange for a free case review, please contact Bernstein Liebhard LLP at (877) 779-1414.

** *

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414

ATTORNEY ADVERTISING. © 2012 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.


Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Follow us on
Visit website